Find a Doctor or Practice Location

Are you a referring physician?
I am searching for a
Reset Form
Nevena Damjanov, MD

Nevena Damjanov, MD Physician

Section Chief Hematology/Oncology, VA Medical Center Associate Professor of Clinical Medicine

Dr. Damjanov is a Penn Medicine employed physician.

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

The comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Patient Comments

Clinical Specialties


  • Medical Oncology

Programs & Centers:

Board Certification:

  • Hematology, 1996
  • Internal Medicine, 1992
  • Medical Oncology, 1995

Clinical Expertise:

  • Colon Cancer
  • Esophageal Cancer
  • Liver Cancer
  • Pancreatic Cancer
  • Pancreatic Neuroendocrine Tumors (Islet Cell Tumors)

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • CVS Health
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Medical School: Hahnemann University Hospital/Drexel University
Residency: Penn State Milton S. Hershey Medical Center
Fellowship: University Hospitals Case Medical Center
Fellowship: Hospital of the University of Pennsylvania


American Medical Association, National American Society of Clinical Oncology, National

Hospital Affiliation

Dr. Damjanov is a Penn Medicine employed physician.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.


Selected Publications:

Lea Lowenfeld MD, Jashodeep Datta MD, Russell S. Lewis Jr., Matthew T. McMillan, Ronac Mamtani MD, Nevena Damjanov MD, Vinay Chandrasakhara MD, Giorgos Karakousis MD, Jeffrey Drebin MD PhD, Douglas Fraker MD, Robert E. Roses MD: Multimodality Treatment of T4 Gastric Cancer in the United States: Utilization Trends and Impact on Survival. Annals of Surgical Oncology 22 (Suppl 3): S863-72,2015.

Vassallo,R; Prechtel-Dunphy,E; Damjanov,N; Tsikouras,A; Favatella,J; Kasbekar,N.: Impact of Comprehensive Pharmacy Services on Patient Centered Outcomes in an Oncology Clinic UHC Pharmacy Council Meeting: New Orleans, LA : 2015.

E.M. Egert, R.D. Johnson, M.M. Watts, J. Booty, N. Damjanov, R. Mohr, M. Lee, N.S. Mungiole, D.E. Kaplan, J. Griffiths, H.A. Shaikh, R.C. Hawley, M.S. Ghosh: A Regional Multidisciplinary Liver Tumor Board improves Access to Hepatocellular Carcinoma Treatment for Patients Geographically Distant from Tertiary Medical Center AASLD, The Liver Meeting 2015 (521): 2015.

Mark H. O'Hara, Maryann Gallagher, Ursina R. Teitelbaum, Bruce J. Giantonio, Nevena Damjanov, Arturo Loaiza-Bonilla, Ravi K. Amaravadi, Daniel F Heitjan, Irina Vasilevskaya, Daniel D. Von Hoff, Ramesh K Ramanathan, Dan Laheru, Ana De Jesus-Acosta, Victor E Velculescu, Peter J. O'Dwyer;: Phase 1 trial of gemcitabine/nab-paclitaxel in combination with the autophagy inhibitor hydroxychloroquine in previously untreated patients with metastatic pancreatic adenocarcinoma. J Clin Oncol 33 : 2015.

Arturo Loaiza-Bonilla, Mark H. O'Hara, Maryann Redlinger, Nevena Damjanov, Ursina R. Teitelbaum, Irina Vasilevskaya, Mark Alan Rosen, Daniel F Heitjan, Ravi K. Amaravadi, Peter J. O'Dwyer;: Phase II trial of autophagy inhibition using hydroxychloroquine (HCQ) with FOLFOX/bevacizumab in the first-line treatment of advanced colorectal cancer. J Clin Oncol 33 : 2015.

Mark H. O'Hara, Christine Edmonds, Michael Farwell, Rodolfo F. Perini, Daniel A. Pryma, Ursina R. Teitelbaum, Bruce J. Giantonio, Nevena Damjanov, Priti Lal, Michael D Feldman, Paul J. Zhang, David A. Mankoff, Maryann Gallagher, Angela DeMichele, David J. Vaughn, Peter J. O'Dwyer: Phase II pharmacodynamic trial of palbociclib in patients with KRAS mutant colorectal cancer. J Clin Oncol 33 (suppl 3; abstr 626): 2015.

Divya Yerramilli, Davendra Sohal, Ursina R. Teitelbaum, Paul Stephen Wissel, Nevena Damjanov, Bruce J. Giantonio, Peter J. O'Dwyer, John Peter Plastaras, Edgar Ben-Josef, James M. Metz, John Kucharczuk, Noel Williams, Smith Apisarnthanarax: Adjuvant chemotherapy after trimodality therapy in locally advanced esophageal cancer. J Clin Oncol 32 : 2014.

Sohal DP, Mykulowycz K, Uehara T, Teitelbaum UR, Damjanov N, Giantonio BJ, Carberry M, Wissel P, Jacobs-Small M, O'Dwyer PJ, Sepulveda A, Sun W.: A phase II trial of gemcitabine, irinotecan and panitumumab in advanced cholangiocarcinoma. Ann Oncol 24 (12): 3061-5,2013.

Sun, W., Sohal, D., Mykulowycz, K., Teitelbaum, U.R., Damjanov, N., Giantonio, B.J., Carberry, M., Wissel, P., Jacobs-Small, M., O’Dwyer, P.J.: An interim evaluation of efficacy and safety of the combination of panitumumab, gemcitabine, and irinotecan in patients with advanced or metastatic cholangiocarcinoma: A phase II study. Journal of Clinical Oncology 30 (328a): 2012.

Davendra Sohal, Ursina R. Teitelbaum, Takeshi Uehara, Kristine Mykulowycz, Christopher D. Watt, Nevena Damjanov, Bruce J. Giantonio, Mary Carberry, Paul Stephen Wissel, Mona Jacobs-Small, Peter J. O'Dwyer, Antonia Sepulveda, Weijing Sun;: A phase II trial of gemcitabine, irinotecan, and panitumumab in advanced cholangiocarcinoma, with correlative analysis of EGFR, KRAS, and BRAF: An interim report. J Clin Oncol 30 : 2012.

Academic Contact Info

Penn Presbyterian Medical Center
51 North 39th Street
103A MAB

Philadelphia, PA 19104
Phone: (215) 662-8488
Fax: (215) 243-3249
Patient appointments: 800-789-PENN (7366)

Related Links